Search
Returning search results with filters:
Remove filter for
Category: Drugs
Remove filter for
Issue: Labelling
Clear all
Search filters
Type
Audience
Category
Issue
Last updated
Recall class
Displaying 16 - 27 of 27 items.
Recall of one lot of pms-Hydromorphone due to packaging error that could potentially lead to overdose
AlertPublic advisory | 2022-08-20
Distribution of EVUSHELD (tixagevimab and cilgavimab for injection) with English-Only Vial and Carton Labels
AlertHealth professional risk communication | 2022-04-14
Distribution of NUVAXOVID with English-only Vial and Carton Labels
AlertHealth professional risk communication | 2022-02-23
PAXLOVID (nirmatrelvir and ritonavir) - Dosing and Dispensing in Renal Impairment, Risk of Serious Adverse Reactions Due to Drug Interactions, and English-Only Labels
AlertHealth professional risk communication | 2022-01-17
Labelling error may lead to patients receiving Linessa 28 birth control pills instead of Linessa 21
AlertPublic advisory | 2019-06-12
Recall of Cannabis for Medical Purposes - CannTrust Inc.
RecallHealth product recall | 2019-01-04
One lot of Equate brand Lens Care System and Multi-Purpose Solution voluntarily recalled because of a labelling error
AlertPublic advisory | 2018-12-21
Several children's strawberry-flavoured acetaminophen syrups recalled because of defective child-resistant safety caps on the bottles
AlertPublic advisory | 2018-11-14
Several store-brand pain or sinus relief tablets recalled because consumers may be unable to access important safety information
AlertPublic advisory | 2018-11-07
Recall of Cannabis for Medical Purposes – Aphria
RecallHealth product recall | 2018-01-30